Tech Company Financing Transactions
Milestone Pharmaceuticals Funding Round
On 6/16/2015, Milestone Pharmaceuticals announced $17 million in Series B investment from Domain Associates and private investors.
Transaction Overview
Company Name
Announced On
6/16/2015
Transaction Type
Venture Equity
Amount
$17,000,000
Round
Series B
Investors
Domain Associates (Lead Investor) (Debra Liebert)
Proceeds Purpose
The funding will be used to complete Phase 2 clinical development of MSP-2017.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1111 Dr.-Frederik-Philips Blvd. 420
Saint-Laurent QC, H4M 2X6
Canada
Saint-Laurent QC, H4M 2X6
Canada
Phone
Website
Email Address
Overview
Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a cardiovascular drug development company developing novel small molecule therapeutics for transient cardiovascular conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Oliveto
Chief Medical Officer
Francis Plat
Vice President
Jeffrey Nelson
Vice President
Douglas Wight
VP - Bus. Development
Lorenz Muller
VP - Manufacturing
Harish Pimplaskar
VP - Regulatory Affairs
Guy Rousseau
Browse more venture capital transactions:
Prev: 6/16/2015: Moonlighting venture capital transaction
Next: 6/16/2015: Connectifier venture capital transaction
Share this article
About Database of VC Transactions
We record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs